#$%^&*AU2020200996A120200227.pdf#####C: Interwo n NRPortbl DCCSXD 17741261-l.docx-20/09/2018 ABSTRACT Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I): x0 X N N:VR1 LH NO O OH (I) including stereoisomers and pharmaceutically acceptable salts thereof, wherein R , X, Y Y2 or L are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
